Chapter 1

Chapter 2

Chapter 3

Chapter 4

Chapter 5

Chapter 6 Drug Coverage

Hypertrophic Cardiomyopathy (HCM)

Vaccines: 2023 Year in Review

Eyecare

Urothelial Carcinoma

Women's Health

Hemophilia

Heart Failure

Vaccines

Neonatal Care

NSCLC

Type II Inflammation

Substance Use Disorder

Gene Therapy

Lung Cancer

Spinal Muscular Atrophy

Post-Acute Care

Liver Disease

Pulmonary Arterial Hypertension

Friedreich Ataxia

Safety & Recalls

Biologics

Asthma

Atrial Fibrillation

Type I Diabetes

Graft Versus Host Disease

COVID-19

Cardiovascular Diseases

Pain

Breast Cancer

Prescription Digital Therapeutics

Reproductive Health

The Improving Patient Access Podcast

Blood Cancer

Ulcerative Colitis

Respiratory Conditions

Multiple Sclerosis

Digital Health

Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies

Population Health

Sleep Disorders

Biosimilars

Plaque Psoriasis

Leukemia and Lymphoma

Oncology

Pediatrics

Urology

Obstetrics-Gynecology & Women's Health

Opioids

Solid Tumors

Autoimmune Diseases

Dermatology

Diabetes

Mental Health

News

Media

Between the Lines

Expert Interviews

K-Cast

Medical World News

Podcasts

Population Health Perspectives

Conferences

Partners

Publications

All Publications

MHE Publication

Formulary Watch Supplements

Supplements And Featured Publications

Events

2024 PBMI Annual National Conference

PBMI MAP

Virtual Events

CME/CE

Resources

PBM Leaders

Subscribe

Articles

Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.

Experts Warn of Ongoing Monkeypox Threat Despite Progress in Vaccination and Behavioral Changes | AIDS 2024

Peter Wehrwein has been the lead editor of Managed Healthcare Executive since February 2020.

Juan Michael Porter II, a prominent healthcare journalist and HIV advocate, spoke to MHE about keeping HIV/AIDS a priority and the dynamics of funding programs and pharmaceutical pricing

 Keeping HIV a Priority, PEPFAR  Funding and Pricing | AIDS 2024

Keri Althoff, Ph.D., discusses how a model developed at Johns Hopkins can assess the comorbidities that patients with HIV may face by 2030.

Johns Hopkins Model Predicts HIV Comorbidities | AIDS 2024

Improving equity for people with HIV requires health leaders to recognize that patients have different risk factors, Keri Althoff, Ph.D., of Johns Hopkins says. 

Addressing HIV Comorbidities and Health Equity | AIDS 2024

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

About Us

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Managed Healthcare Executive

Facebook

Twitter

LinkedIn

Resource Centers

Eye Care

Spotlight

ATS 

AHIP

Asembia’s Specialty Pharmacy Summit

2023 PBMI Annual National Conference

AMCP Annual

ASRS

Business

Business Strategy

Chronic Disease

Consumers

Drug Costs

Drug Pipeline

Formulary

Health Management

Health/Disease Strategy

Hospitals & Providers

Industry Analysis

Pharmacy

Politics and Policy

Practice Management

Reimbursement

Technology

Should “On-Demand” Treatments for Parkinson's disease OFF episodes be used earlier?

Meet the Speakers

PROGRAM OBJECTIVES

In this live broadcast, the experts will: